Literature DB >> 9715944

Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994.

M I Meltzer1, J G Rigau-Pérez, G G Clark, P Reiter, D J Gubler.   

Abstract

This study presents the disability-adjusted life years (DALYs), a non-monetary economic measure of impact, lost to dengue in Puerto Rico for the period 1984-1994. Data on the number of reported cases, cases with hemorrhagic manifestations, hospitalizations, and deaths were obtained from a surveillance system maintained at the Dengue Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention (San Juan, PR). The reported cases were divided into two age groups (0-15 years old and >15 years old), and then multiplied by predetermined factors (10 for 0-15 years; 27 for >15 years) to allow for age-related under-reporting of cases. Severity of dengue was modeled by classifying cases into three groups: dengue fever, dengue with severe manifestations, and hospitalized cases. Each group was assigned a different number of days lost because of dengue-related disability. Dengue caused an average of 658 DALYs per year per million population (SE = 114, range = 145-1,519). A multivariate sensitivity analysis, which simultaneously altered the values of six input variables, produced a mean of 580 DALYs/year/million population, with a maximum average of 1,021 DALYs/year/million population, and a maximum, single-year estimate for 1994 of 2,153 DALYs/million population. The most important input was the number of days lost to classic dengue. The DALYs/year/million population lost to dengue in Puerto Rico are much greater than previous estimates concerning the impact of dengue hemorrhagic fever alone. The loss to dengue is similar to the losses per million population in the Latin American and Caribbean region attributed to any of the following diseases or disease clusters; the childhood cluster (polio, measles, pertussis, diphtheria, tetanus), meningitis, hepatitis, or malaria. The loss is also of the same order of magnitude as any one of the following: tuberculosis, sexually transmitted diseases (excluding human immunodeficiency virus), tropical cluster (e.g., Chagas' disease, leishmaniasis), or intestinal helminths. The results objectively suggest that when governments and international funding agencies allocate resources for research and control, dengue should be given a priority equal to many other infectious diseases that are generally considered more important.

Entities:  

Mesh:

Year:  1998        PMID: 9715944     DOI: 10.4269/ajtmh.1998.59.265

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  44 in total

1.  Educational campaign versus malathion spraying for the control of Aedes aegypti in Colima, Mexico.

Authors:  F Espinoza-Gómez; C Moises Hernández-Suárez; R Coll-Cárdenas
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

2.  Dengue in Costa Rica: the gap in local scientific research.

Authors:  Adriana Troyo; Sherri L Porcelain; Olger Calderón-Arguedas; Dave D Chadee; John C Beier
Journal:  Rev Panam Salud Publica       Date:  2006-11

3.  Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Authors:  Zachary S Wettstein; Michael Fleming; Aileen Y Chang; David J Copenhaver; Angela R Wateska; Sarah M Bartsch; Bruce Y Lee; Rajan P Kulkarni
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

Review 4.  Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey.

Authors:  Dagna Constenla; Cristina Garcia; Noah Lefcourt
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

Review 5.  The global distribution of yellow fever and dengue.

Authors:  D J Rogers; A J Wilson; S I Hay; A J Graham
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

6.  High household economic burden caused by hospitalization of patients with severe dengue fever cases in Can Tho province, Vietnam.

Authors:  Pham Thi Tam; Nguyen Tan Dat; Le Minh Huu; Xuan Cuc Pham Thi; Hoang Minh Duc; Tran Cong Tu; Simon Kutcher; Peter A Ryan; Brian H Kay
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

7.  Cost and disease burden of dengue in Cambodia.

Authors:  Julien Beauté; Sirenda Vong
Journal:  BMC Public Health       Date:  2010-08-31       Impact factor: 3.295

8.  Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators.

Authors:  James A Potts; Robert V Gibbons; Alan L Rothman; Anon Srikiatkhachorn; Stephen J Thomas; Pra-On Supradish; Stephenie C Lemon; Daniel H Libraty; Sharone Green; Siripen Kalayanarooj
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

9.  High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data.

Authors:  Katherine Standish; Guillermina Kuan; William Avilés; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2010-03-16

10.  Lineage II of Southeast Asian/American DENV-2 is associated with a severe dengue outbreak in the Peruvian Amazon.

Authors:  Maya Williams; Sandra V Mayer; William L Johnson; Rubing Chen; Evgeniya Volkova; Stalin Vilcarromero; Steven G Widen; Thomas G Wood; Luis Suarez-Ognio; Kanya C Long; Kathryn A Hanley; Amy C Morrison; Nikos Vasilakis; Eric S Halsey
Journal:  Am J Trop Med Hyg       Date:  2014-07-07       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.